Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 19/20 | 1.00 |
| ▸ | HTR2A | P28223 | 17/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | HTR2B | P41595 | 1/20 | 0.62 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9232780 | 1.00 | HTR2C (1.00) | HTR2CHTR2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL7092716 | 1.00 | HTR2C (1.00) | HTR2CHTR2ACYP1A2CYP3A4CYP2C9 | |
| Fumaric Acid SCHEMBL7091387 | 0.88 | HTR2C (0.78) | HTR2CHTR2ACYP1A2CYP3A4CYP2C9 | |
| Fumaric Acid SCHEMBL7091385 | 0.88 | HTR2C (0.78) | HTR2CHTR2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL7997689 | 0.87 | HTR2C (0.77) | HTR2CHTR2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL4033420 | 0.87 | HTR2C (0.77) | HTR2CHTR2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL8959778 | 0.84 | HTR2C (0.72) | HTR2CHTR2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL8959781 | 0.84 | HTR2C (0.72) | HTR2CHTR2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL9233993 | 0.82 | HTR2C (1.00) | HTR2CHTR2ACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL9233990 | 0.82 | HTR2C (1.00) | HTR2CHTR2ACYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5494928-A | FOR CENTRAL NERVOUS SYSTEM DISORDERS, BLOCKING SEROTONIN RECEPTORS, ANTIDEPRESSANTS | HOFFMANN-LA ROCHE INC. (US) | 1996-02-27 | — | — | US | disclosed |